Sinopharm (01099) announced its first quarter financial results, with a net profit attributable to shareholders of 14.57 billion yuan, a year-on-year increase of 2.59%.

Sinopharm (01099) released financial information for the three-month quarter ending on March 31, 2025. The total operating revenue was 141.662 billion yuan, a year-on-year decrease of 3.81%; net profit attributable to the owners of the parent company was 1.457 billion yuan, a year-on-year increase of 2.59%; and basic earnings per share were 0.47 yuan.